About 20% of those screened will fail the screening, so about 21 will join the trial, which is far more than in previous months.
This figure is likely to increase in future months, as sites get more used to the trial, and they start to see some improvements in patients on the trial.
- Forums
- ASX - By Stock
- Ann: Clinical Trial Update
About 20% of those screened will fail the screening, so about 21...
Featured News
Add DLM (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.227M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
DLM (ASX) Chart |
Day chart unavailable